Global Stem Cell Technologies and Applications Market 2018-2018 - Visiongain Report

LONDON, March 13, 2018 /PRNewswire/ --

Cancer, Cardiovascular, CNS, Other Disease Areas and Non-Therapeutic Applications

Report Details 

The global stem cell technologies and applications marke [https://www.visiongain.com/Report/2141/Global-Stem-Cell-Technologies-and-Applications-Market-2018-2018 ] t is estimated to have reached $12,040 million and is expected to grow at a CAGR of 13.2% in the first half of the forecast period. The market is expected to grow at a CAGR of 11.5% from 2017 to 2028.

(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 284-page report  [https://www.visiongain.com/Report/2141/Global-Stem-Cell-Technologies-and-Applications-Market-2018-2018 ] you will receive 114 charts- all unavailable elsewhere.

The 284-page report provides clear detailed insight into the global stem cell technologies and applications market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope 

- Global Stem Cell Technologies and Applications Market [https://www.visiongain.com/Report/2141/Global-Stem-Cell-Technologies-and-Applications-Market-2018-2018 ] forecasts from 2018-2028

- Global Stem Cell Technologies and Applications submarket forecasts from 2018-2028: - Cancer treatment - Cardiovascular therapy - CNS - Other therapies - Non-therapeutic applications

- Individual revenue forecast to 2028 for selected top products: - MSC-100-IV (Mesoblast) - Hearticellgram-AMI (Pharmicell) - CardioRel (Reliance Life Sciences) - Osteocel Plus (NuVasive) - Trinity Evolution and Elite (Orthofix) - CARTISTEM (MEDIPOST)

- Analysis of the most promising pipeline therapies in each therapeutic segment

- Discussion on regulatory environments and developments in the US, Japan, Europe and other leading countries

- Analysis of what drives and restrains the market

- This study also discusses other influences on that field, including these: - Haematopoietic stem cell transplantation (HSCT) - Embryonic stem cells (ESCs), induced pluripotent adult (IPSCs) and parthenogenetic cells - Uses for umbilical cord blood and related technologies, including cellular and blood banking - Agents for osteogenesis and treating autoimmune conditions - Applications in cell-based assays, diagnostics and drug development.

Visiongain's [http://www.visiongain.com ] study is intended for anyone requiring commercial analyses for the Global Stem Cell Technologies and Applications Market. You find data, trends and predictions.

Buy our report today Global Stem Cell Technologies and Applications Market 2018-2018: Cancer, Cardiovascular, CNS, Other Disease Areas and Non-Therapeutic Applications.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

Or click on: https://www.visiongain.com/Report/2141/Global-Stem-Cell-Technologies-and-Applications-Market-2018-2018

List of Companies Mentioned in the Report 

Aastrom Biosciences

Advanced Cell Technology

Alder Biopharmaceuticals

Alkem

AllCells

Allergan

AlloSource

Americord

Americord

Amgen

Amgen

Angiocrine Bioscience

Angiocrine Bioscience

Anterogen

Anterogen

Apceth

Arteriocyte

Arteriocyte

Associated Press

Astellas Pharma

Asterias Biotherapeutics

Asterias Biotherapeutics

Athersys

Athersys

Auriga Ventures

Axiogenesis

Axiogenesis

Bank a Tooth

Baxter

Baxter Healthcare

BaYi Brain Hospital

BioCardia

BioCardia

BioE

BioE

BioEden

BioEden

Biogenea-Cellgenea

Bioheart, Inc.

Biologic Therapies

BioMet Orthopedics

Biosciences

BioTechnology

BioTime

BioTime Asia

Blackstone

Blackstone Medical

Bloodworks

Bluebird Bio

Brain Somatic Mosaicism

BrainStorm Cell Therapeutics

Caladrius Biosciences

California Institute for Regenerative Medicine (CIRM)

Calimmune

Capricor

Cardio3

Caribou

Carolinas Cord Blood Bank (CCBB)

Casey Eye Institute

Cedars-Sinai Heart Institute

Celgene

Cell Cure Neurosciences

Cell Research Groups

Cell Therapy Catapult

Cellartis

CellCentric

Cellectis

Cellerant Therapeutics

Cellerix

CELLTREE

Cellular Biomedicine Group (CBMG)

Cellular Dynamics International

Center for International Blood and Marrow Transplant Research (CIBMTR)

Centers for Medicare & Medicaid Services

Cephalon

Cesca Therapeutics

Ceylad

China Cord Blood Corporation

China Cord Blood Corporation

China Regenerative Medicine International Limited (CRMI)

Chugai Pharmaceutical Co. Ltd.

CJ CheilJedang

Clal Biotechnologies Industries

Cleveland Biolabs

Cleveland Cord Blood Center

ClinImmune Labs

Cochrane

Cognate BioServices

Cook General BioTechnology

Cord Blood America

Cordlife Group

CordVida

CRISPR Therapeutics

Cryo-Cell International

CryoCord

CryoHaldco

Cryonix CJSC

Cryo-Save

CryoViva

CXR Biosciences

Cytori Therapeutics

Denali Ventures

Dendreon

Dong-A Pharmaceuticals Co.

Dynamics

Elbit Imaging

Elbit Medical Technologies

Eli Lilly

EpiStem

ESI BIO

EuroStemCell

Fate Therapeutics

FDS Pharma

Fondazione Centro San Raffaele

Fondazione Telethon

Forbion Capital Partners

Forticell Bioscience

Future Health Biobank

Gamida Cell

Gemabank

Gene Cell International

Genetico

Genetrix Group

Geron Corporation

Gilead

GlobalStem

Globocan

GSK

Howard Hughes Medical Institute

Human Stem Cells Institute

ImmunoCellular Therapeutics

Immunovative Therapies

Indian Department of Biotechnology

Insception Biosciences

Intellia Therapeutics

IntelliCell Biosciences

IPS Academia Japan

Isar Medical Centre

Israel Healthcare Venture

Japan Institute of Biomedical Research.

JCR Pharmaceuticals

JingYuan Bio.

Johnson & Johnson

Kirby Institute

Lifebank Cryogenics

LifebankUSA

LifeCord

LifeMap Sciences

LifeMap Solutions

LifeSouth Community Blood Centers Inc

Lonza

Maxcyte

Mayo Clinic

MedCell Bioscience

MEDIPOST

Medistem Panama

Medistem Panama Inc.

Medtronic

Mesoblast

Miltenyi Biotec

National Dental Pulp laboratory

NeoStem

Neuralstem

New England Cord Blood Bank

New York Blood Center

Novartis

NovoCell

NurOwn

Nuvasive

Ocata Therapeutics

OncoCyte

Opexa Therapeutics

OrLife Bio

Orthofix

Osiris Therapeutics

Pahrump Valley Times

Pfizer

Pharmicell

Pharmsynthez

Plasticell

Pluristem Therapeutics

Polyphor

Precious Cell Group

Prix Galien

PsychENCODE

Pulp Laboratory

Q Therapeutics

Quest Biomedical

ReCyte Therapeutics

Ree Labs

Regenerative Sciences

Regenerex

Regeneron

Regeneus

Reliance Group

Reliance Life Sciences

ReNeuron

RepliCel Life Sciences

Reprobank

ReproCELL

RIKEN Center for Developmental Biology

Roche

Roslin Cellab

RTI Biologics

RTI Surgical

RUSNANO Corporation

RVC OJSC

SanBio

Sangamo BioSciences

Sanofi

S-Evans Biosciences

Spinesmith Partners

SSM Cardinal Glennon

SSM Cardinal Glennon Children's Medical Center

Stem Cell Bank

Stemade

Stemcell Technologies  

StemCore

StemCyte

Stemedica Cell Technologies

StemGen

StemImmune Inc

Stemina Biomarker Discovery

StemSave

Store-a-tooth

SynBio

Systems

Takara Bio

Takeda

TAP Biosystems

Teva

The Zon Laboratory

TiGenix

Tong Yuan Stem Cell

Tooth Bank

TrakCel

Transcell Biologics Pvt Ltd.

Translational Biosciences

U.S. Stem Cell, Inc

UCL Business PLC

UCL Institute of Ophthalmology

UCLA

uniQure

US Stem Cell, Inc.

Valeant

VAULT Sc Inc.

Vericel Corporation

Vericel Corporation

Vesta Therapeutics

ViaCord

ViaCyte

ViroMed

Vita34

Vitro Biopharma

WA Optimum Health Care

WHO

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

    Photo: 
    http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

SOURCE Visiongain